Trial Outcomes & Findings for Improving Hypertension Medication Adherence for Older Adults (NCT NCT05610059)
NCT ID: NCT05610059
Last Updated: 2026-07-31
Results Overview
The Medication Event Monitoring System (MEMS®Cap) assesses objective medication adherence using the smart pill bottle cap. Digital sensors in the track cap automatically record the date and time of cap opening and upload the information to AARDEX Medication Adherence Software. Percentage of medication taken at the correct time frame.
COMPLETED
NA
200 participants
3 months, 6 months
2026-07-31
Participant Flow
Additional Information: The difference between the number of participants enrolled in the study and the number who started the study is because only those with hypertension medication adherence of 90% or less started the study. Data Element Definition: A 28-day adherence monitoring period after enrollment determined adherence (90% or less to receive intervention) before participant randomization.
Participant milestones
| Measure |
Blood Pressure Technology System M
These participants received information about high blood pressure, medications, and strategies that can be used to remember to take medications for managing blood pressure. They completed a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
These participants received information about high blood pressure and medications. They completed a mid-assessment at 3-months and a post-assessment at 6-months.
|
Enrolled But Not Randomized/Treated
These participants completed the baseline data collection but were excluded after the 28-day adherence monitoring period, after which they had hypertension medication adherence greater than 90%.
|
|---|---|---|---|
|
Overall Study
STARTED
|
34
|
32
|
134
|
|
Overall Study
COMPLETED
|
27
|
30
|
0
|
|
Overall Study
NOT COMPLETED
|
7
|
2
|
134
|
Reasons for withdrawal
| Measure |
Blood Pressure Technology System M
These participants received information about high blood pressure, medications, and strategies that can be used to remember to take medications for managing blood pressure. They completed a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
These participants received information about high blood pressure and medications. They completed a mid-assessment at 3-months and a post-assessment at 6-months.
|
Enrolled But Not Randomized/Treated
These participants completed the baseline data collection but were excluded after the 28-day adherence monitoring period, after which they had hypertension medication adherence greater than 90%.
|
|---|---|---|---|
|
Overall Study
Adherence >90% after 28-day monitoring period
|
0
|
0
|
134
|
|
Overall Study
Lost to Follow-up
|
7
|
2
|
0
|
Baseline Characteristics
Improving Hypertension Medication Adherence for Older Adults
Baseline characteristics by cohort
| Measure |
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
Enrolled But Not Randomized/Treated
n=134 Participants
Participants completed the baseline data collection but were excluded after the 28-day adherence monitoring period after which they had hypertension medication adherence greater than 90%. Other reasons for exclusion included having no time, no longer interested, share same household as another participant, did not want to change medication strategy, and scheduling conflict.
|
Total
n=200 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
75.26 years
STANDARD_DEVIATION 6.65 • n=9 Participants
|
74.00 years
STANDARD_DEVIATION 7.44 • n=27 Participants
|
74.16 years
STANDARD_DEVIATION 6.04 • n=267 Participants
|
74.65 years
STANDARD_DEVIATION 7.02 • n=265 Participants
|
|
Sex: Female, Male
Female
|
23 Participants
n=9 Participants
|
27 Participants
n=27 Participants
|
76 Participants
n=267 Participants
|
126 Participants
n=265 Participants
|
|
Sex: Female, Male
Male
|
11 Participants
n=9 Participants
|
5 Participants
n=27 Participants
|
58 Participants
n=267 Participants
|
74 Participants
n=265 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
1 Participants
n=267 Participants
|
2 Participants
n=265 Participants
|
|
Race (NIH/OMB)
Asian
|
3 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
4 Participants
n=267 Participants
|
7 Participants
n=265 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
1 Participants
n=267 Participants
|
1 Participants
n=265 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=9 Participants
|
2 Participants
n=27 Participants
|
1 Participants
n=267 Participants
|
5 Participants
n=265 Participants
|
|
Race (NIH/OMB)
White
|
27 Participants
n=9 Participants
|
28 Participants
n=27 Participants
|
124 Participants
n=267 Participants
|
179 Participants
n=265 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
1 Participants
n=267 Participants
|
2 Participants
n=265 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=9 Participants
|
2 Participants
n=27 Participants
|
2 Participants
n=267 Participants
|
4 Participants
n=265 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=9 Participants
|
1 Participants
n=27 Participants
|
2 Participants
n=267 Participants
|
5 Participants
n=265 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
32 Participants
n=9 Participants
|
31 Participants
n=27 Participants
|
132 Participants
n=267 Participants
|
195 Participants
n=265 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=267 Participants
|
0 Participants
n=265 Participants
|
|
Region of Enrollment
United States
|
34 Participants
n=9 Participants
|
32 Participants
n=27 Participants
|
134 Participants
n=267 Participants
|
200 Participants
n=265 Participants
|
|
Medication adherence (MEMS Cap)
|
62.76 Percentage
STANDARD_DEVIATION 28.32 • n=9 Participants
|
70.72 Percentage
STANDARD_DEVIATION 22.20 • n=27 Participants
|
96.40 Percentage
STANDARD_DEVIATION 3.23 • n=267 Participants
|
66.62 Percentage
STANDARD_DEVIATION 25.66 • n=265 Participants
|
|
Medication Adherence Report Scale (MARS-5)
|
24.03 Score on a scale
STANDARD_DEVIATION 1.17 • n=9 Participants
|
23.69 Score on a scale
STANDARD_DEVIATION 1.38 • n=27 Participants
|
24.26 Score on a scale
STANDARD_DEVIATION 1.28 • n=267 Participants
|
23.86 Score on a scale
STANDARD_DEVIATION 1.28 • n=265 Participants
|
PRIMARY outcome
Timeframe: 3 months, 6 monthsThe Medication Event Monitoring System (MEMS®Cap) assesses objective medication adherence using the smart pill bottle cap. Digital sensors in the track cap automatically record the date and time of cap opening and upload the information to AARDEX Medication Adherence Software. Percentage of medication taken at the correct time frame.
Outcome measures
| Measure |
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
|---|---|---|
|
Medication Adherence (MEMS Cap)
3 months
|
67.29 Percentage
Standard Deviation 0.31
|
53.72 Percentage
Standard Deviation 0.32
|
|
Medication Adherence (MEMS Cap)
6 months
|
63.47 Percentage
Standard Deviation 0.32
|
53.56 Percentage
Standard Deviation 0.36
|
PRIMARY outcome
Timeframe: 3 months, 6 monthsThe Medication Adherence Report Scale (MARS-5) is a 5-item self-report scale to assess medication adherence related to the frequency of not taking a prescribed dose of medication or not taking the dose prescribed. Self-report score of 5-25. Item scores are summed for a total scale score, where higher scores reflect greater medication adherence. Scale: 5=never, 4=rarely, 3=sometimes, 2=often, and 1=always.
Outcome measures
| Measure |
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
|---|---|---|
|
Medication Adherence Report Scale (MARS-5)
3 months
|
23.62 Score on a scale
Standard Deviation 1.83
|
24.00 Score on a scale
Standard Deviation 1.48
|
|
Medication Adherence Report Scale (MARS-5)
6 months
|
23.94 Score on a scale
Standard Deviation 1.48
|
23.66 Score on a scale
Standard Deviation 1.68
|
SECONDARY outcome
Timeframe: Baseline, 3-months, 6-monthsThe mean of two seated blood pressure readings taken at least 15 minutes apart using a validated automated device. 6-month change in mean seated systolic BP among M system users versus E system users.
Outcome measures
| Measure |
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
|---|---|---|
|
Systolic Blood Pressure (SBP)
Baseline
|
131.93 mm Hg
Standard Deviation 17.93
|
133.44 mm Hg
Standard Deviation 20.06
|
|
Systolic Blood Pressure (SBP)
3 months
|
133.29 mm Hg
Standard Deviation 15.27
|
129.34 mm Hg
Standard Deviation 17.13
|
|
Systolic Blood Pressure (SBP)
6 months
|
134.63 mm Hg
Standard Deviation 18.65
|
130.59 mm Hg
Standard Deviation 21.04
|
SECONDARY outcome
Timeframe: Baseline, 3-months, 6-monthsThe Treatment Self-Regulation Questionnaire (TSRQ) assesses perceived autonomy, treatment-related motivation, and health behavior change. A 15-item questionnaire measures motivation and regulation styles that individuals employ to manage their health-related treatments or behaviors. Scale: 1=Not at all true to 7=Very true. Score 1-7 for each of the following components: TSRQ Autonomous motivation, TSRQ Introjected regulation, TSRQ External regulation, and TSRQ Amotivation. The subscales are averaged to report the mean TSRQ score. Higher numbers indicate higher autonomous motivation, controlled motivation, or amotivation. 6-month change in perceived autonomy among M system users versus E system users.
Outcome measures
| Measure |
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
|---|---|---|
|
Perceived Autonomy
Baseline
|
6.66 Score on a scale
Standard Deviation 0.50
|
6.65 Score on a scale
Standard Deviation 0.49
|
|
Perceived Autonomy
3 months
|
6.80 Score on a scale
Standard Deviation 0.38
|
6.66 Score on a scale
Standard Deviation 0.49
|
|
Perceived Autonomy
6 months
|
6.84 Score on a scale
Standard Deviation 0.35
|
6.76 Score on a scale
Standard Deviation 0.49
|
SECONDARY outcome
Timeframe: Baseline, 3-months, 6-monthsThe Perceived Competence Scale (PCS) is a 4-item questionnaire designed to measure self-perceptions of competence in different contexts (e.g., managing medications). We modified the questions to reflect blood pressure medications. Scale: 1=Not at all true to 7=Very true. Each score on the scale is summed, and a total score is reported (ranges between 4 and 28), with higher scores indicating higher perceived competence with medication adherence. 6-month change in perceived competence among M system users versus E system users.
Outcome measures
| Measure |
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
|---|---|---|
|
Perceived Competence
Baseline
|
24.88 Score on a scale
Standard Deviation 4.99
|
25.94 Score on a scale
Standard Deviation 3.60
|
|
Perceived Competence
3 months
|
25.00 Score on a scale
Standard Deviation 4.90
|
25.59 Score on a scale
Standard Deviation 3.56
|
|
Perceived Competence
6 months
|
25.29 Score on a scale
Standard Deviation 4.86
|
26.16 Score on a scale
Standard Deviation 3.33
|
SECONDARY outcome
Timeframe: Baseline, 3-months, 6-monthsThe Mobile Device Proficiency Questionnaire (MDPQ) assesses experience with mobile devices, comfort level, and successful use. A 16-item survey measures older adults' proficiency and comfort level in using mobile devices such as smartphones and tablets, including navigating various features and functions. Each questionnaire item is assigned a value from 1 to 5 (1 = Never Tried; 5 = Very Easily). Eight subscale scores are computed by taking the mean of the items within each respective subscale. The overall score is calculated by adding together all subscale scores. The MDPQ-16 total score ranges from 8 to 40, with higher scores reflecting greater proficiency. 6-month change in mobile device proficiency among M system users versus E system users.
Outcome measures
| Measure |
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
|---|---|---|
|
Mobile Device Proficiency
6 months
|
33.21 Score on a scale
Standard Deviation 6.89
|
34.41 Score on a scale
Standard Deviation 5.21
|
|
Mobile Device Proficiency
Baseline
|
32.93 Score on a scale
Standard Deviation 6.62
|
33.88 Score on a scale
Standard Deviation 5.73
|
|
Mobile Device Proficiency
3 months
|
33.26 Score on a scale
Standard Deviation 6.00
|
34.58 Score on a scale
Standard Deviation 4.58
|
SECONDARY outcome
Timeframe: Baseline, 6 monthsThe Hypertension Knowledge Level Scale (HK-LS) consists of 22 questions with 6 sub-dimensions and scores, including: HK-LS Definition \[0-2\], HK-LS Medical treatment \[0-4\], HK-LS Drug Compliance \[0-4\], HK-LS Lifestyle \[0-5\], HK-LS Diet \[0-2\], and HK-LS Complications \[0-5\]. The sub-dimension scores are summed to generate an overall score. The HK-LS Overall ranges from 0 to 22, with a higher score indicating higher knowledge about hypertension.
Outcome measures
| Measure |
Blood Pressure Technology System M
n=34 Participants
These participants will receive information about high blood pressure, medications and strategies that can be used to take medications and manage blood pressure. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
Blood Pressure Technology System E
n=32 Participants
These participants receive information about high blood pressure and medications. They will complete a mid-assessment at 3-months and a post-assessment at 6-months.
|
|---|---|---|
|
Hypertension Knowledge Level Scale
Baseline
|
18.02 Score on a scale
Standard Deviation 2.72
|
17.97 Score on a scale
Standard Deviation 2.52
|
|
Hypertension Knowledge Level Scale
6 months
|
18.62 Score on a scale
Standard Deviation 2.57
|
18.59 Score on a scale
Standard Deviation 3.17
|
Adverse Events
Blood Pressure Technology System M
Blood Pressure Technology System E
Enrolled But Not Randomized/Treated
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place